Back to 
Brevan Howard Capital Management LP
Brevan Howard Capital Management LP
KPTI
2 quarters
Position history for Brevan Howard Capital Management LP's holdings in Karyopharm Therapeutics Inc.
Yes. Brevan Howard holds 309,817 shares of KPTI (Karyopharm Therapeutics), worth $3M, as of its Q2 2026 13F filing. It increased the position by 97,450 shares (+45.9%) from Q1 2026. Brevan Howard has held KPTI since Q1 2026, across 2 quarterly 13F filings.
Current Value
$3M
Current Shares
309,817
Total Value Change
+$1.8M
Total Shares Change
+97,450
Quarter-by-Quarter History
Other major holders of KPTI: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Goldman Sachs Group Inc., BlackRock, Inc.